Christopher Kim Apimeds Pharmaceuticals Us, Inc. (APUS) insider trading activity

Shares Held (Direct Ownership) 278K

n/a 3M change

n/a 12M change

Total Value Held N/A

Christopher Kim Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2025	BUY Grant, award, or other acquisition	-	250,000 Added 47.39%	277,500 Common Stock, par valu...
May 14 2025	BUY Open market or private purchase	$14,377 $1.86 p/Share	7,730 Added 21.94%	27,500 Common Stock, par valu...
May 13 2025	BUY Open market or private purchase	$35,981 $1.82 p/Share	19,770 Added 50.0%	19,770 Common Stock, par valu...

Chairman and CMO

Hopewell, NJ

Receive a notification when an Institution or Guru buys or sells APUS shares.

Notify only if

Value

Get notified when an Apimeds Pharmaceuticals Us, Inc. insider buys or sells APUS shares.

Notify only if

Operation

Value

Type

Receive news related to Apimeds Pharmaceuticals US, Inc.